AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart …

SC Smith Jr, J Allen, SN Blair, RO Bonow, LM Brass… - Circulation, 2006 - Am Heart Assoc
• Ask about tobacco use status at every visit. I (B)• Advise every tobacco user to quit. I (B)•
Assess the tobacco user's willingness to quit. I (B)• Assist by counseling and developing a …

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management

JMO Arnold, P Liu, C Demers, P Dorian… - Canadian Journal of …, 2006 - Elsevier
Heart failure remains a common diagnosis, especially in older individuals. It continues to be
associated with significant morbidity and mortality, but major advances in both diagnosis …

Outcome of heart failure with preserved ejection fraction in a population-based study

RS Bhatia, JV Tu, DS Lee, PC Austin… - … England Journal of …, 2006 - Mass Medical Soc
Background The importance of heart failure with preserved ejection fraction is increasingly
recognized. We conducted a study to evaluate the epidemiologic features and outcomes of …

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

HL Hillege, D Nitsch, MA Pfeffer, K Swedberg… - Circulation, 2006 - Am Heart Assoc
Background—Decreased renal function has been found to be an independent risk factor for
cardiovascular outcomes in patients with chronic heart failure (CHF) with markedly reduced …

Standards of medical care in diabetes-2006

American Diabetes Association - Diabetes care, 2006 - search.proquest.com
Diabetes is a chronic illness that requires continuing medical care and patient self-
management education to prevent acute complications and to reduce the risk of long-term …

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in …

A Ducharme, K Swedberg, MA Pfeffer… - American heart …, 2006 - Elsevier
BACKGROUND: Atrial fibrillation (AF) is frequent in patients with chronic heart failure (CHF).
Experimental and small patient studies have demonstrated that blocking the renin …

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

A Ahmed, MW Rich, TE Love… - European heart …, 2006 - academic.oup.com
Aims To determine the effects of digoxin on all-cause mortality and heart failure (HF)
hospitalizations, regardless of ejection fraction, accounting for serum digoxin concentration …

Role of angiotensin II in cardiovascular disease—therapeutic implications of more than a century of research

CM Ferrario - Journal of the Renin-angiotensin-aldosterone …, 2006 - journals.sagepub.com
More than a century of research on the renin-angiotensin system (RAS) has uncovered the
widespread involvement of angiotensin II (Ang II) in the pathophysiology of cardiovascular …

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox

MH Strauss, AS Hall - Circulation, 2006 - Am Heart Assoc
838 medication have significant differences with regard to their ancillary pharmacological
properties and thereby also their profile at a molecular/cellular level. Furthermore, these …

Renin inhibition with aliskiren: where are we now, and where are we going?

M Azizi, R Webb, J Nussberger… - Journal of …, 2006 - journals.lww.com
With the development of aliskiren, blockade of the renin–angiotensin–aldosterone system
(RAAS) at the level of the interaction of renin with a substrate has become a clinical reality …